Data presented at Microbiology Society Annual Conference, Belfast, 4-7 April 2022 LONDON, April 5, 2022 /PRNewswire/ -- UK genomics company, RevoluGen Ltd. (RevoluGen or the Company), welcomes...

Data being presented at the EHRA 2022 shows Cardiologs' deep neural network model is better than Apple Watch ECG 2.0 algorithm at detecting & classifying irregular heart rhythms PARIS and BOSTON,...

Aptiv PLC (NYSE: APTV), a global technology company focused on making mobility safer, greener, and more connected, announced that Aptiv's Chief Financial Officer and Senior Vice President,...

First disease-specific data module in neuroscience, Qdata™ SMA, helps power exclusive real-world evidence generation into a rare-disease patient journey from one of world's largest clinical...

Final results from long-term, open-label, repeat-dose Phase 3 study of VALTOCO® (diazepam nasal spray) for episodes of frequent seizure activity include findings on ease of dosing and quality of life